John Stamos - Public Service Announcement
KFWB Radio Interview.
Cancer experts at Long Beach Memorial Hospital are hoping to pioneer a new way of treating cancer nationwide.
KFWB Radio
6:37 pm
12/11/03
JACK POPEJOY: Cancer experts at Long Beach Memorial Hospital are hoping to pioneer a new way of treating cancer nationwide.
Dr. Robert Nagourney, of the hospital’s Todd Cancer Institute, says he’s planning to conduct a pilot study to show that a treatment therapy tailored to a specific cancer patient and their condition will be far more effective than administering a treatment protocol used for a certain type of cancer.
DR. ROBERT NAGOURNEY: We decided to focus on the more difficult of the cancers, the gastrointestinal and non-small-cell lung cancers. Those always made the least headway.
Our intent here will be to take small portions of each patient’s tissue, study them in a laboratory model, and pick those drugs most likely to work.
POPEJOY: The pilot study’s going to track the progress of almost 200 terminally-ill cancer patients who have not undergone chemotherapy, and are in the advanced stages of that disease .
KFWB Radio
7 :55 pm
12/11/03
JACK POPEJOY: Cancer experts at Long Beach Memorial Hospital say there’s a far more effective way to treat terminally-ill cancer patients than most doctors in the country realize.
And as KFWB’s Laurie Kellman reports, they are now out to prove it.
LAURIE KELLMAN: Doctors at the Todd Cancer Institute at Long Beach Memorial Hospital are hoping to bring a better quality of life, and more time, to terminally-ill cancer patients.
Dr. Robert Nagourney is planning to launch a pilot study, treating patients with a therapy specifically tailored to their condition, instead of a treatment protocol intended to treat the type of cancer and stage it’s at.
And surprisingly, he says it won’t involve any new cancer drugs or cancer treatments.
DR. ROBERT NAGOURNEY: The current study constitutes just under 200 patients. Our intent will be to biopsy these patients at the time of initial diagnosis. They will not have received prior chemotherapy, and we will give them the very best combination that we can identify in the laboratory.
The drugs will be chosen from FDA-approved agents, so our intent here is to use available drugs better.
KELLMAN: Dr. Nagourney says all patients in the study will be profiled, and will only be given drugs that look active for their specific condition and cancer they have.
Terminal-cancer patients who want to participate in the study can call the Todd Cancer Institute at Long Beach Memorial Hospital.
In Long Beach, Laurie Kellman, KFWB News 980
|
©2010 Rational Therapeutics. All rights reserved.